Pentoxifylline inhibits agonist-induced vasoconstriction in vascular smooth muscle and spontaneous peristalsis in isolated ileum

Oncology Research

Volumn 15, Issue 2, 2005, Pages 81-86

  Ruddock, Mark W ^a   Hirst, David G ^a,b  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Artery; Ileum; Lisofylline; Pentoxifylline; Phenylephrine; Smooth muscle

Indexed keywords

DRUG METABOLITE; LISOFYLLINE; PENTOXIFYLLINE; PHENYLEPHRINE;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; DIGESTIVE SYSTEM FUNCTION DISORDER; DOSE RESPONSE; DRUG MECHANISM; FLOW KINETICS; ILEUM; INTESTINE CONTRACTION; IONIZING RADIATION; MALE; NONHUMAN; OSCILLATION; OXYGENATION; PERISTALSIS; PRIORITY JOURNAL; RADIATION INJURY; RAT; TUMOR BLOOD FLOW; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

EID: 20444451284     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504005775082011     Document Type: Article

References (38)

1. Lee, I.; Levitt, S. H.; Song, C. W. Improved tumour oxygenation and radiosensitization by combination with nicotinamide and pentoxifylline. Int. J. Radiat. Biol. 64:237-244; 1993.
2. Zywietz, F.; Bohm, L.; Sagowski, C.; Kehrl, W. Pentoxifylline enhances tumor oxygenation and radiosensitivity in rat rhabdomyosarcomas during continuous hyperfractionated irradiation. Strahlenther. Onkol. 180:306-314; 2004.
3. Dion, M. W.; Hussey, D. H.; Osborne, J. W. The effect of pentoxifylline on early and late radiation injury following fractionated irradiation in C3H mice. Int. J. Radiat. Oncol. Biol. Phys. 17:101-107; 1989.
4. Okunieff, P.; Augustine, E.; Hicks, J. E.; Cornelison, T. L.; Altemus, R. M.; Naydich, B. G.; Ding, I.; Huser, A. K.; Abraham, E. H.; Smith, J. J.; Coleman, N.; Gerber, L. H. Pentoxifylline in the treatment of radiation-induced fibrosis. J. Clin. Oncol. 22:2207-2213; 2004.
5. Aygenc, E.; Celikkanat, S.; Kaymakci, M.; Aksaray, F.; Ozdem, C. Prophylactic effect of pentoxifylline on radiotherapy complications: A clinical study. Otolaryngol. Head Neck Surg. 130:351-356; 2004.
6. Kim, S. H.; Khil, M. S.; Ryu, S.; Kim, J. H. Enhancement of radiation response on human carcinoma cells in culture by pentoxifylline. Int. J. Radiat. Oncol. Biol. Phys. 25: 61-65; 1993.
7. Sperduto, P. W.; Song, C. W.; Levitt, S. H. The in vitro radiosensitization of human glioblastoma with pentoxifylline. Am. J. Clin. Oncol. 16:407-411; 1993.
8. Geldof, A. A.; Plaizier, M. A.; Duivenvoorden, I.; Ringelberg, M.; Versteegh, R. T.; Newling, D. W.; Teule, G. J. Cell cycle perturbations and radiosensitization effects in a human prostate cancer cell line. J. Cancer Res. Clin. Oncol. 129:175-182; 2003.
9. Bennewith, K. L.; Durand, R. E. Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity. Br. J. Cancer 85:1577-1584; 2001.
10. Lee, I.; Biaglow, J. E.; Lee, J.; Cho, M. J. Physiological mechanisms of radiation sensitization by pentoxifylline. Anticancer Res. 20:4605-4609; 2000.
11. Collingridge, D. R.; Rockwell, S. Pentoxifylline improves the oxygenation and radiation response of BA1112 rat rhabdomyosarcomas and EMT6 mouse mammary carcinomas. Int. J. Cancer 90:256-264; 2000.
12. Lee, I.; Boucher, Y.; Demhartner, T. J.; Jain, R. K. Changes in tumour blood flow, oxygenation and interstitial fluid pressure induced by pentoxifylline. Br. J. Cancer 74:492-496; 1994.
13. Sensky, P. L.; Prise, V. E.; Ward, A. E.; Hirst, D. G. The effects of pentoxifylline on the relative perfusion of tumours growing in three sites in the mouse. Br. J. Cancer 73:1110-1114; 1993.
14. Song, C. W.; Hasegawa, T.; Kwon, H. C.; Lyons, J. C.; Levitt, S. H. Increase in tumor oxygenation and radiosensitivity caused by pentoxifylline. Radiat. Res. 130:205-210; 1992.
15. Angelkort, B.; Maurin, N.; Boateng, K. Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease. Curr. Med. Res. Opin. 6:255-258; 1979.
16. Sonkin, P. L.; Freedman, S. F.; Needham, D.; Rao, K. M.; Hatchell, D. L. Pentoxifylline modulates deformability, F-actin content, and superoxide anion production of polymorphonuclear leukocytes from diabetic cats. Exp. Eye Res. 55:831-838; 1992.
17. Honess, D. J.; Kitamoto, Y.; Rampling, M. R.; Bleehen, N. M. Nicotinamide and pentoxifylline increase human leucocyte filterability: A possible mechanism for reduction of acute hypoxia. Br. J. Cancer Suppl. 27:S236-240; 1996.
18. Bahra, P. S.; Rainger, G. E.; Wautier, J. L.; Nash, G. B. Effects of pentoxifylline on the different steps during adhesion and transendothelial migration of flowing neutrophils. Cell Biochem. Funct. 19:249-257; 2001.
19. Kelleher, D. K.; Thews, O.; Vaupel, P. Regional perfusion and oxygenation of tumors upon methylxanthine derivative administration. Int. J. Radiat. Oncol. Biol. Phys. 42: 861-864; 1998.
20. Ward, A.; Clissold, S. P. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 34:50-59; 1987.
21. Bussink, J.; Stratford, M. R.; van der Kogel, A. J.; Kolkes, L. K.; Kaanders, J. H. Pharmacology and toxicity of nicotinamide combined with domperidone during fractionated radiotherapy. Radiother. Oncol. 63:285-291; 2002.
22. Ruddock, M. W.; Burns, D. M.; Murphy, L. E.; O'Rourke, M. G.; Hirst, D. G. The effect of nicotinamide on spontaneous and induced activity in smooth and skeletal muscle. Radiother. Oncol. 56:251-257; 2000.
23. Wong, J. S.; Ara, G.; Keyes, S. R.; Herbst, R.; Coleman, C. N.; Teicher, B. A. Lisofylline as a modifier of radiation therapy. Oncol. Res. 8:513-518; 1996.
24. Hirst, D. G.; Kennovin, G. D.; Flitney, F. W. The radiosensitizer nicotinamide inhibits arterial vasoconstriction. Br. J. Radiol. 67:795-799; 1994.
25. De Sanctis, M. T.; Cesarone, M. R.; Belcaro, G.; Nicolaides, A. N.; Griffin, M.; Incandela, L.; Bucci, M.; Geroulakos, G.; Ramaswami, G.; Vasdekis, S.; Agus, G.; Bavera, P.; Ippolito, E. Treatment of intermittent claudication with pentoxifylline: A 12-month, randomized trial-walking distance and microcirculation. Angiology 53(Suppl. 1):S7-12; 2002.
26. De Sanctis, M. T.; Belcaro, G.; Cesarone, M. R.; Ippolito, E.; Nicolaides, A. N.; Incandela, L.; Geroulakos, G. Treatment of venous ulcers with pentoxifylline: A 12-month, double-blind, placebo controlled trial. Microcirculation and healing. Angiology 53(Suppl. 1):S49-51; 2002.
27. Incandela, L.; Cesarone, M. R.; Belcaro, G.; Steigerwalt, R.; De Sanctis, M. T.; Nicolaides, A. N.; Griffin, M.; Geroulakos, G.; Ramaswami, G. Treatment of vascular retinal disease with pentoxifylline: A controlled, randomized trial. Angiology 53(Suppl. 1):S31-34; 2002.
28. Sonkin, P. L.; Sinclair, S. H.; Hatchell, D. L. The effect of pentoxifylline on retinal capillary blood flow velocity and whole blood viscosity. Am. J. Ophthalmol. 115:775-780; 1993.
29. Seiffge, D. Pentoxifylline: Its influence on the interaction of blood cells with the vessel wall. Atherosclerosis Suppl. 131:S27-28; 1997.
30. Gude, R. P.; Binda, M. M.; Boquete, A. L.; Bonfil, R. D. Inhibition of endothelial cell proliferation and tumor-induced angiogenesis by pentoxifylline. J. Cancer Res. Clin. Oncol. 127:625-630; 2001.
31. Honess, D. J.; Dennis, I. F.; Bleehen, N. M. Pentoxifylline: Its pharmacokinetics and ability to improve tumour perfusion and radiosensitivity in mice. Radiother. Oncol. 28:208-218; 1993.
32. Sonkin, P. L.; Chen, L. E.; Seaber, A. V.; Hatchell, D. L. Vasodilator action of pentoxifylline on microcirculation of rat cremaster muscle. Angiology 43:462-469; 1992.
33. Sonkin, P. L.; Kelly, L. W.; Sinclair, S. H.; Hatchell, D. L. Pentoxifylline increases retinal capillary blood flow velocity in patients with diabetes. Arch. Ophthalmol. 111: 1647-1652; 1993.
34. Grossmann, M.; Braune, J.; Ebert, U.; Kirch, W. Dilatory effects of phosphodiesterase inhibitors on human hand veins in vivo. Eur. J. Clin. Pharmacol. 54:35-39; 1998.
35. Jull, A.; Waters, J.; Arroll, B. Pentoxifylline for treatment of venous leg ulcers: A systematic review. Lancet 359: 1550-1554; 2002.
36. Ruddock, M. W.; Hirst, D. G. Nicotinamide relaxes vascular smooth muscle by inhibiting mysoin light chain kinase-dependent signalling pathways: Implications for anticancer efficacy. Oncol. Res. 14:483-489; 2004.
37. Burns, D. M.; Ruddock, M. W.; Walker, M. D.; Allen, J. M.; Kennovin, G. D.; Hirst, D. G. Nicotinamide-inhibited vasoconstriction: Lack of dependence on agonist signalling pathways. Eur. J. Pharmacol. 374:213-220; 1999.
38. Sigurdardottir, G. R.; Nilsson, C.; Odin, P.; Grabowski, M. Cardiovascular effects of domperidone in patients with Parkinson's disease treated with apomorphine. Acta Neurol. Scand. 104:92-96; 2001.